Science Explorer Back to mapMap
Discussion
Institution · Cleveland Eye Clinic

Most cited papers from Cleveland Eye Clinic

Cleveland Eye Clinic

What are the most cited papers from Cleveland Eye Clinic?

The most cited paper from Cleveland Eye Clinic is "Ranibizumab for Neovascular Age-Related Macular Degeneration" (Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al., 2006), with 5,931 citations. Next come "Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration" (3,535) and "Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes" (2,927).

Showing 50 of 60 papers. Every paper with more than 264 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ranibizumab for Neovascular Age-Related Macular Degeneration Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine Open access 4 Oct 2006 5,931
2 Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine 4 Oct 2006 3,535
3 Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes Philip R. Schauer, Deepak L. Bhatt, John Patrick Kirwan et al. · New England Journal of Medicine Open access 15 Feb 2017 2,927
4 Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration Jeffrey S. Heier, David M. Brown, Victor N. Chong et al. · Ophthalmology 17 Oct 2012 2,522
5 Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Daniel Francis Martin, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology Open access May 2012 1,726
6 A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants Lars G. Fritsche et al. · Nature Genetics Open access162 authors 21 Dec 2015 1,645
7 Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study David M. Brown, Mark Michels, Peter K. Kaiser et al. · Ophthalmology 31 Dec 2008 1,323
8 Uveal Melanoma: Trends in Incidence, Treatment, and Survival Arun D. Singh, Mary E. Turell, Allan K. Topham · Ophthalmology 28 Jun 2011 1,286
9 The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole Jay S. Duker, Peter K. Kaiser, Susanne Binder et al. · Ophthalmology 17 Sep 2013 1,203
10 Ranibizumab for Macular Edema following Central Retinal Vein Occlusion David M. Brown, Peter A. Campochiaro, Rishi P. Singh et al. · Ophthalmology 10 Apr 2010 1,160
11 Endogenous HMGB1 regulates autophagy Daolin Tang, Rui Kang, Kristen M. Livesey et al. · The Journal of Cell Biology Open access 6 Sep 2010 964
12 Intravitreal Aflibercept for Diabetic Macular Edema Jean‐François Korobelnik et al. · Ophthalmology Open access 8 Jul 2014 822
13 Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ursula Margarethe Schmidt-Erfurth et al. · Ophthalmology 29 Sep 2013 822
14 Seven new loci associated with age-related macular degeneration Lars G. Fritsche et al. · Nature Genetics Open access156 authors 3 Mar 2013 812
15 Oxidative damage–induced inflammation initiates age-related macular degeneration Joe G. Hollyfield, Vera L. Bonilha, Mary E. Rayborn et al. · Nature Medicine Open access 27 Jan 2008 716
16 Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration Maureen G. Maguire, Daniel Francis Martin, Gui‐Shuang Ying et al. · Ophthalmology Open access 2 May 2016 710
17 A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Jian Hua Qi, Quteba Ebrahem, Nina Zobenica Moore et al. · Nature Medicine 24 Mar 2003 660
18 Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis Careen Y. Lowder · Archives of Ophthalmology 11 Jan 2011 656
19 Intravitreal Aflibercept for Diabetic Macular Edema David M. Brown et al. · Ophthalmology 18 Jul 2015 624
20 Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein Hirotaka Kazama, Jean‐Ehrland Ricci, John M. Herndon et al. · Immunity Open access Jul 2008 620
21 Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance Max A. Tischfield et al. · Cell Open access 2010 615
22 Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials Juan E. Grunwald, Ebenezer Daniel, Jiayan Huang et al. · Ophthalmology Open access 29 Sep 2013 592
23 Acute Endophthalmitis Following Cataract Surgery Mehran Taban · Archives of Ophthalmology May 2005 561
24 Biomechanics and wound healing in the cornea William Joseph Dupps, Steven E. Wilson · Experimental Eye Research Open access 26 May 2006 513
25 Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization Xin Ye, Yanshu Wang, Hugh B. Cahill et al. · Cell Open access Oct 2009 479
26 TFOS DEWS II iatrogenic report José Álvaro Pereira Gomes, Dimitri T. Azar, Christophe Baudouin et al. · The Ocular Surface Jul 2017 463
27 Intravitreal Aflibercept for Diabetic Macular Edema Jeffrey S. Heier et al. · Ophthalmology 18 Sep 2016 432
28 Paneth cell trypsin is the processing enzyme for human defensin-5 Dipankar Ghosh, Edith Martin Porter, Bo Shen et al. · Nature Immunology 20 May 2002 429
29 Wound Healing in the Cornea Marcelo V. Netto, Rajiv R. Mohan, Renato Ambr sio et al. · Cornea 17 Jun 2005 427
30 Comparison of Optical Coherence Tomography and Ultrasound Biomicroscopy for Detection of Narrow Anterior Chamber Angles Sunita Radhakrishnan · Archives of Ophthalmology Aug 2005 415
31 Acute endophthalmitis following intravitreal triamcinolone acetonide injection Darius M. Moshfeghi, Peter K. Kaiser, Ingrid Ursula Scott et al. · American Journal of Ophthalmology 28 Oct 2003 399
32 Incidence of retinoblastoma in the USA: 1975-2004 Erin Broaddus, A Topham, Arun D. Singh · British Journal of Ophthalmology 11 Jul 2008 399
33 Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy Jeffrey G. Gross, Adam R. Glassman, Danni Liu et al. · JAMA Ophthalmology Open access 25 Jul 2018 395
34 Global Retinoblastoma Presentation and Analysis by National Income Level Global Retinoblastoma Study Group et al. · JAMA Oncology Open access473 authors 27 Feb 2020 382
35 Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results Peter K. Kaiser, David M. Brown, Kang Zhang et al. · American Journal of Ophthalmology 26 Nov 2007 365
36 Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Arshad M. Khanani et al. · The Lancet Open access226 authors 8 Sep 2023 364
37 Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab Jordi Monés, SUNIL K. SRIVASTAVA, Glenn J. Jaffe et al. · Ophthalmology Open access 15 Nov 2020 357
38 Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials Ebenezer Daniel, Cynthia Ann Toth, Juan E. Grunwald et al. · Ophthalmology Open access 4 Dec 2013 337
39 Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration Xiaorong Gu, Susan Gillette Meer, Masaru Miyagi et al. · Journal of Biological Chemistry Open access Oct 2003 331
40 Keratocyte apoptosis after corneal surgery. Marco C. Helena, FIONA BAERVELDT, Woo Jung Kim et al. · PubMed Feb 1998 329
41 Identification of an angiogenic factor that when mutated causes susceptibility to Klippel–Trenaunay syndrome Xiao‐Li Tian, Rajkumar Kadaba, Sun-Ah You et al. · Nature Feb 2004 322
42 Detection of Primary Angle Closure Using Anterior Segment Optical Coherence Tomography in Asian Eyes Winifred Nolan, Jovina Li Shuen See, Paul T. K. Chew et al. · Ophthalmology 28 Oct 2006 319
43 Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration Gui‐Shuang Ying, Jiayan Huang, Maureen G. Maguire et al. · Ophthalmology Open access 6 Oct 2012 314
44 Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity Carl W. Baker, Adam R. Glassman, Wesley T. Beaulieu et al. · JAMA Open access 30 Apr 2019 306
45 Uveal Melanoma: Epidemiologic Aspects Arun D. Singh, Lina Bergman, Stefan Seregard · Ophthalmology Clinics of North America Mar 2005 303
46 Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013) Mary E. Aronow, Allan K. Topham, Arun D. Singh · Ocular Oncology and Pathology Open access 12 Oct 2017 300
47 VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis Tarô Matsumoto, Svante Bohman, Johan Dixelius et al. · The EMBO Journal Open access 16 Jun 2005 298
48 Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials Glenn J. Jaffe, Daniel Francis Martin, Cynthia Ann Toth et al. · Ophthalmology Open access May 2013 297
49 Visual Acuity, Refractive Error, and Endothelial Cell Density Six Months After Descemet Stripping and Automated Endothelial Keratoplasty (DSAEK) Steven B. Koenig, Douglas J. Covert, William Joseph Dupps et al. · Cornea 8 Jun 2007 293
50 The corneal fibrosis response to epithelial–stromal injury André A. M. Torricelli, Abirami Santhanam, Jiahui Wu et al. · Experimental Eye Research Open access 10 Dec 2015 290

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.